Abstract
Objectives
Bisphenol A (BPA), a raw material commonly used in the manufacture of resins such as polycarbonate and epoxy, is a possible xenoestrogen that is hypothesized to disrupt the human endocrine system. Humans are widely exposed to BPA. We investigated the urinary concentration of BPA in infertile Japanese women and its possible association with endometriosis.
Materials and Methods
We recruited 166 women (aged 20–45) who had complained of infertility and visited a university hospital in Tokyo. The subjects were interviewed and their urine samples were obtained prior to a laparoscopic diagnosis of endometriosis between January 2000 and December 2001. Urinary total BPA concentration in 140 eligible urine samples was then measured using enzymatic deconjugation of glucuronide and sulfate and high-performance liquid chromatography isotope-dilution tandem mass spectrometry.
Results
Median (25th–75th percentile) unadjusted and creatinine-adjusted urinary BPA concentrations were 1.6 (0.69–2.8) μg/L and 0.80 (0.45–1.3) μg/g creatinine. No significant monotonic association of endometriosis with urinary BPA concentration was observed. Median urinary BPA concentration in women with stage 0–1 endometriosis (0.74 μg/g creatinine) did not significantly differ from that in those with stage II–IV endometriosis (0.93 μg/g creatinine) (p for difference=0.24).
Conclusions
This study, based on a larger number of samples than those in previous studies in Japan and using the most reliable analytical method currently available, showed that urinary concentrations of BPA in women who consulted a physician for infertility were not higher than those in other populations. Moreover, no association between urinary BPA concentration and endometriosis was found in this cross-sectional study.
Key words: endocrine disruptor, HPLC-MS/MS, epidemiology, urine, xenoestrogen
References
- (1).Miyamoto K, Kotake M. Estimation of daily bisphenol A intake of Japanese individuals with emphasis on uncertainty and variability. Environ Sci. 2006;13:15–29. [PubMed]
- (2).European Commission. 4,4′-isopropylidenediphenol (bisphenol-A). European Union risk assessment report. EUR 20843 EN; 2003.
- (3).Miyamoto K, Kawasaki H. Risk assessment of bisphenol A. Tokyo: Maruzen Co., Ltd.; 2005. (Article in Japanese)
- (4).Japan Environment Agency. Strategic Programs on Environmental Endocrine Disruptors ’98 (SPEED ’98). http://www. env.go.jp/en/chemi/ed/speed98/sp98.html; 1998.
- (5).Ministry of Environment. MOE’s Perspectives on Endocrine Disrupting Effects of Substances—ExTEND 2005—.http://www.env.go.jp/en/chemi/ed/extend2005_full.pdf; 2005.
- (6).Kim YH, Kim CS, Park S, Han SY, Pyo MY, Yang M. Gender differences in the levels of bisphenol A metabolites in urine. Biochem Biophys Res Commun. 2003;312:441–448. [DOI] [PubMed]
- (7).Ye X, Kuklenyik Z, Needham LL, Calafat AM. Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2005;383:638–644. [DOI] [PubMed]
- (8).Ouchi K, Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;780:365–370. [DOI] [PubMed]
- (9).Fujimaki K, Arakawa C, Yoshinaga J, Watanabe C, Serizawa S, Imai H, et al. Estimation of intake level of bisphenol A in Japanese pregnant women based on measurement of urinary excretion level of the metabolite. Nippon Eiseigaku Zasshi. 2004;59:403–408. (Article in Japanese, with English abstract) [DOI] [PubMed]
- (10).Arakawa C, Fujimaki K, Yoshinaga J, Imai H, Serizawa S, Shiraishi H. Daily urinary excretion of bisphenol A. Environ Health Prevent Med. 2004;9:22–26. [DOI] [PMC free article] [PubMed]
- (11).American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43:351–352. [DOI] [PubMed]
- (12).Tsukino H, Hanaoka T, Sasaki H, Motoyama, H, Hiroshima M, Tanaka T, et al. Associations between serum levels of selected organochlorine compounds and endometriosis in infertile Japanese women. Environ Res. 2005;99:118–125. [DOI] [PubMed]
- (13).Tsukino H, Hanaoka T, Sasaki H, Motoyama H, Hiroshima M, Tanaka T, et al. Fish intake and serum levels of organochlorines among Japanese women. Sci Total Environ. 2006; 359:90–100. [DOI] [PubMed]
- (14).Itoh H, Yoshida K, Masunaga S. Evaluation of the effect of governmental control of human exposure to two phthalates in Japan using a urinary biomarker approach. Int J Hyg Environ Health. 2005;208:237–245. [DOI] [PubMed]
- (15).Kawasaki T, Uezono K, Itoh K, Ueno M. Prediction of 24-hour urinary creatinine excretion from age, body weight and height of an individual and its application. Nippon Koshu Eisei Zasshi. 1991;38:567–574. (Article in Japanese, with English abstract) [PubMed]
- (16).Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H. Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem. 2004;14:57–63.
- (17).Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol. 2002;15:1281–1287. [DOI] [PubMed]
- (18).Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999–2000. Environ Health Perspect. 2004;112:331–338. [DOI] [PMC free article] [PubMed]
- (19).Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005;113:391–395. [DOI] [PMC free article] [PubMed]
- (20).Yang M, Kim SY, Chang SS, Lee IS, Kawamoto T. Urinary concentrations of bisphenol A in relation to biomarkers of sensitivity and effect and endocrine-related health effects. Environ Mol Mutagen. 2006;47:571–578. [DOI] [PubMed]
- (21).European Food Safety Authority. Opinion of the scientific panel AFC related to 2,2-bis(4-hydroxyphenyl)propane. http://www.efsa.europa.eu/en/science/afc/afc_opinions/bisphenol_a.html; 2007.
- (22).Matsumoto A, Kunugita N, Kitagawa K, Isse T, Oyama T, Foureman GL, et al. Bisphenol A levels in human urine. Environ Health Perspect. 2003;111:101–104. [DOI] [PMC free article] [PubMed]
- (23).Higuchi M, Miyata D, Kawamura S, Ueda E, Imanaka M, Tonogai Y. Estimation of daily intake of phenols in hospital meal samples. Shokuhin Eiseigaku Zasshi. 2004;45:339–343. (Article in Japanese, with English abstract) [DOI] [PubMed]
- (24).Imanaka M, Sasaki K, Nemoto S, Ueda E, Murakami E, Miyata D, et al. Determination of bisphenol A in foods using GC/MS. Shokuhin Eiseigaku Zasshi. 2001;42:71–78. (Article in Japanese, with English abstract) [DOI] [PubMed]
- (25).Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18:177–200. [DOI] [PubMed]
- (26).Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955:11–22. [DOI] [PubMed]
- (27).Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin North Am. 2003;30:1–19. [DOI] [PubMed]
- (28).Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82:1501–1508. [DOI] [PubMed]
- (29).Ye X, Kuklenyik Z, Needham LL, Calafat AM. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem. 2005;77:5407–5413. [DOI] [PubMed]
- (30).Kawaguchi M, Sakui N, Okanouchi N, Ito R, Saito K, Izumi S, et al. Stir bar sorptive extraction with in situ derivatization and thermal desorption-gas chromatography-mass spectrometry for measurement of phenolic xenoestrogens in human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;820:49–57. [DOI] [PubMed]